Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
The European Journal of Neuroscience|July 29, 2014
Disease stage determines the efficacy of treatment of a paediatric neurodegenerative diseaseSofia Hassiotis, Helen Beard, Amanda Luck, et al.Molecular Genetics and Metabolism|March 22, 2015
Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA miceHelen Beard, Amanda J Luck, Sofia Hassiotis, et al.Acta Neuropathologica Communications|November 18, 2020
Is the eye a window to the brain in Sanfilippo syndrome?Helen Beard, Glyn Chidlow, Daniel Neumann, et al.Experimental Neurology|April 26, 2011
Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIATina Rozaklis, Helen Beard, Sofia Hassiotis, et al.The European Journal of Neuroscience|March 24, 2009
Examination of intravenous and intra-CSF protein delivery for treatment of neurological diseaseKim M Hemsley, Amanda J Luck, Allison C Crawley, et al.Gene|October 4, 2011
Helper-dependent canine adenovirus vector-mediated transgene expression in a neurodegenerative lysosomal storage disorderAdeline A Lau, Tina Rozaklis, Sandy Ibanes, et al.Journal of Inherited Metabolic Disease|November 26, 2014
Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brainBarbara King, Neil Marshall, Helen Beard, et al.Experimental Neurology|November 9, 2023
Repetitive, non-invasive imaging of neurodegeneration, and prevention of it with gene replacement, in mice with Sanfilippo syndromeKim M Hemsley, Helen Beard, Glyn Chidlow, et al.Neurobiology of Disease|May 10, 2011
Enzyme replacement reduces neuropathology in MPS IIIA dogsAllison C Crawley, Neil Marshall, Helen Beard, et al.Journal of Inherited Metabolic Disease|January 10, 2021
Is SGSH heterozygosity a risk factor for early-onset neurodegenerative disease?Meghan L Douglass, Helen Beard, Andrew Shoubridge, et al.Pageof 3